Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA priority review
Pharma
Karyopharm reports Xpovio miss, FDA filing in separate cancers
Reporting a new miss in one cancer indication, Karyopharm is plowing ahead with plans to advance its XPO1 inhibitor Xpovio in another.
Fraiser Kansteiner
Jul 31, 2026 10:00am
J&J data set up Imaavy for expansion to treat anemic disorder
Jun 11, 2026 10:36am
Fierce Biotech
At CNPV hearing, industry support meets ‘concern’ from experts
Jun 5, 2026 5:00am
Sanofi asks out of FDA's CNPV program for Tzield expansion: Stat
May 6, 2026 4:00pm
Fierce Biotech
Senate hearing takes aim at FDA's rare disease review process
Feb 26, 2026 3:50pm
FDA’s rare pediatric voucher program revived by funding bill
Feb 4, 2026 3:12pm
